Assetmark Inc. Acquires New Holdings in Core Laboratories Inc. (NYSE:CLB)

Assetmark Inc. purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,500 shares of the oil and gas company’s stock, valued at approximately $26,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLB. Disciplined Growth Investors Inc. MN grew its stake in shares of Core Laboratories by 26.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company’s stock worth $104,761,000 after acquiring an additional 1,192,871 shares during the last quarter. Eagle Asset Management Inc. acquired a new stake in shares of Core Laboratories in the third quarter worth $3,531,000. Fisher Asset Management LLC grew its stake in shares of Core Laboratories by 19.5% in the third quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company’s stock worth $18,350,000 after acquiring an additional 161,278 shares during the last quarter. Rice Hall James & Associates LLC acquired a new stake in shares of Core Laboratories in the fourth quarter worth $1,960,000. Finally, Barclays PLC boosted its stake in Core Laboratories by 288.2% during the third quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after buying an additional 62,042 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Up 4.1 %

CLB opened at $15.31 on Monday. Core Laboratories Inc. has a fifty-two week low of $12.95 and a fifty-two week high of $25.13. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. The firm’s fifty day moving average price is $17.10 and its two-hundred day moving average price is $18.31. The company has a market capitalization of $716.83 million, a P/E ratio of 23.19, a P/E/G ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. On average, analysts anticipate that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.26%. Core Laboratories’s dividend payout ratio is 6.06%.

Analyst Ratings Changes

Separately, Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $15.00 to $16.00 in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.50.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.